Medicine
Volume 35, Issue 11 , Pages 585-586 , November 2007

Anticonvulsants

References 

  1. Durelli L, Massazza U, Cavallo R. Carbamazepine toxicity and poisoning. Incidence, clinical features and management. Med Toxicol Adverse Drug Exp. 1989;4:95–107
  2. Hojer J, Malmlund H-O, Berg A. Clinical features in 28 consecutive cases of laboratory confirmed massive poisoning with carbamazepine alone. J Toxicol Clin Toxicol. 1993;31:449–458
  3. Neuvonen PJ, Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. Eur J Clin Pharmacol. 1980;17:51–57
  4. Boldy DAR, Heath A, Ruddock S, et al. Activated charcoal for carbamazepine poisoning. Lancet. 1987;1:1027
  5. Larsen JR, Larsen LS. Clinical features and management of poisoning due to phenytoin. Med Toxicol Adverse Drug Exp. 1989;4:229–245
  6. Neuvonen PJ, Elfving SM, Elonen E. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man. Eur J Clin Pharmacol. 1978;13:213–218
  7. Weichbrodt GD, Elliott DP. Treatment of phenytoin toxicity with repeated doses of activated charcoal. Ann Emerg Med. 1987;16:1387–1389
  8. Isbister GK, Balit CR, Whyte IM, Dawson A. Valproate overdose: a comparative cohort study of self poisonings. Br J Clin Pharmacol. 2003;55:398–404
  9. Spiller HA, Krenzelok EP, Klein-Schwartz W, et al. Multicenter case series of valproic acid ingestion: serum concentrations and toxicity. J Toxicol Clin Toxicol. 2000;38:755–760
  10. Khoo SH, Leyland MJ. Cerebral edema following acute sodium valproate overdose. J Toxicol Clin Toxicol. 1992;30:209–214
  11. Farrar HC, Herold DA, Reed MD. Acute valproic acid intoxication: enhanced drug clearance with oral-activated charcoal. Crit Care Med. 1993;21:299–301
  12. Meek MF, Broekroelofs J, Yska JP, et al. Valproic acid intoxication: sense and non-sense of haemodialysis. Neth J Med. 2004;62:333–336
  13. Klein-Schwartz W, Shepherd JG, Gorman S, Dahl B. Characterization of gabapentin overdose using a poison center case series. J Toxicol Clin Toxicol. 2003;41:11–15
  14. Buckley NA, Whyte IM, Dawson AH. Self-poisoning with lamotrigine. Lancet. 1993;342:1552–1553
  15. Lofton AL, Klein-Schwartz W. Evaluation of lamotrigine toxicity reported to poison centers. Ann Pharmacother. 2004;38:1811–1815
  16. O’Donnell J, Bateman DN. Lamotrigine overdose in an adult. J Toxicol Clin Toxicol. 2000;38:659–660
  17. Barrueto F, Williams K, Howland MA, et al. A case of levetiracetam (Keppra) poisoning with clinical and toxicokinetic data. J Toxicol Clin Toxicol. 2002;40:881–884
  18. Spiller HA, Winter ML, Ryan M, et al. Retrospective evaluation of tiagabine overdose. Clin Toxicol. 2005;43:855–859
  19. Cantrell FL, Ritter M, Himes E. Intentional overdose with tiagabine: an unusual clinical presentation. J Emerg Med. 2004;27:271–272
  20. Ostrovskiy D, Spanaki MV, Morris GL. Tiagabine overdose can induce convulsive status epilepticus. Epilepsia. 2002;43:773–774
  21. Lofton AL, Klein-Schwartz W. Evaluation of toxicity of topiramate exposures reported to poison centers. Hum Exp Toxicol. 2005;24:591–595
  22. Fakhoury T, Murray L, Seger D, et al. Topiramate overdose: clinical and laboratory features. Epilepsy Behav. 2002;3:185–189
  23. Traub SJ, Howland MA, Hoffman RS, Nelson LS. Acute topiramate toxicity. J Toxicol Clin Toxicol. 2003;41:987–990

PII: S1357-3039(07)00265-4

doi: 10.1016/j.mpmed.2007.08.001

Medicine
Volume 35, Issue 11 , Pages 585-586 , November 2007

Article Tools